Renal oxygenation defects in the spontaneously hypertensive rat:: Role of AT1 receptors

被引:77
作者
Welch, WJ
Baumgärtl, H
Lübbers, D
Wilcox, CS
机构
[1] Georgetown Univ, Med Ctr, Div Nephrol & Hypertens, Washington, DC 20007 USA
[2] Georgetown Univ, Ctr Hypertens & Renal Dis Res, Washington, DC USA
[3] Max Planck Inst Mol Physiol, D-44139 Dortmund, Germany
关键词
hypertension; candesartan; oxidative stress; nitric oxide; angiotensin II; angiotensin receptor blocker (ARB);
D O I
10.1046/j.1523-1755.2003.00729.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. The spontaneously hypertensive rat (SHR) has oxidative stress and enhanced O-2 usage () relative to tubular sodium transport (T-Na ). Angiotensin II (Ang II) acting on Type I receptors (AT(1) -R) causes renal oxidative stress and functional nitric oxide (NO) deficiency that could enhance O-2 usage. Therefore, we investigated the hypothesis that AT(1) -Rs mediate the inefficient renal oxygenation in the SHR. Methods. Groups of SHR and WKY received vehicle (Veh), candesartan (Cand) or hydralazine + hydrochlorothiazide + reserpine (HHR) for two weeks. Results. Compared to WKY + Veh, the elevated BP of SHR + Veh (153 +/- 3 vs 115 +/- 3 mm Hg; P < 0.001) was normalized by Cand (117 +/- 4) or HHR (113 +/- 5 mm Hg). The reduced renal blood flow of SHR + Veh (2.4 +/- 0.3 vs. 4.1 +/- 0.3 mL . min(-1) . 100 g(-1) ) was increased (P < 0.05) by Cand (3.6 +/- 0.3) and HHR (3.2 +/- 0.2). Compared to WKY + Veh, SHR + Veh had a 50% reduction in T-Na : (16.9 +/- 2.0 vs. 7.8 +/- 0.9 mumol: mumol(-1) , P < 0.01) that was unchanged by HHR (8.6 +/- 1.1), but was increased by Cand (13.2 +/- 1.4; P < 0.01). The pO(2) of outer cortex was lower in SHR + Veh than WKY + Veh (31 +/- 3 vs. 41 +/- 2 mm Hg; P < 0.05) and it was not changed significantly by HHR (37 +/- 2) but was normalized by Cand (44 +/- 3 mm Hg; P < 0.01). The pO(2) in the deep cortex also was lower in SHR + Veh than WKY + Veh (18 +/- 3 vs. 30 +/- 3 mm Hg; P < 0.005) and was not changed significantly by HHR (19 +/- 2), but was increased by Cand (25 +/- 3 mm Hg; P < 0.05). Conclusions. The reduced pO(2) in outer and inner cortex, and inefficient utilization of O-2 for Na+ transport in the SHR kidney can be ascribed to the effects of AT(1) -R, largely independent of blood pressure.
引用
收藏
页码:202 / 208
页数:7
相关论文
共 37 条
[1]   Renal and metabolic clearance of N-acetyl-seryl-aspartyl-lysyl-proline (AcSDKP) during angiotensin-converting enzyme inhibition in humans [J].
Azizi, M ;
Ezan, E ;
Reny, JL ;
Wdzieczak-Bakala, J ;
Gerineau, V ;
Ménard, J .
HYPERTENSION, 1999, 33 (03) :879-886
[2]   Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline [J].
Azizi, M ;
Rousseau, A ;
Ezan, E ;
Guyene, TT ;
Michelet, S ;
Grognet, JM ;
Lenfant, M ;
Corvol, P ;
Menard, J .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03) :839-844
[3]  
Baumgartl H., 1983, POLAROGRAPHIC OXYGEN, P37, DOI [10.1007/978-3-642-81863-9_4, DOI 10.1007/978-3-642-81863-9_4]
[4]  
BAYLIS C, 1994, J AM SOC NEPHROL, V5, P211
[5]   INCREASED OXIDATIVE-METABOLISM IN RENAL TUBULES FROM SPONTANEOUSLY HYPERTENSIVE RATS [J].
BRAZY, PC ;
KLOTMAN, PE .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (05) :F818-F825
[6]   Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney [J].
Chabrashvili, T ;
Tojo, A ;
Onozato, ML ;
Kitiyakara, C ;
Quinn, MT ;
Fujita, T ;
Welch, WJ ;
Wilcox, CS .
HYPERTENSION, 2002, 39 (02) :269-274
[7]   DIE ABHANGIGKEIT DES O2-VERBRAUCHS DER NIERE VON DER NA-RUCKRESORPTION [J].
DEETJEN, P ;
KRAMER, K .
PFLUGERS ARCHIV FUR DIE GESAMTE PHYSIOLOGIE DES MENSCHEN UND DER TIERE, 1961, 273 (06) :636-&
[8]   HIGH SERUM ERYTHROPOIETIN LEVELS ARE NORMALIZED DURING TREATMENT OF CONGESTIVE HEART-FAILURE WITH ENALAPRIL [J].
FYHRQUIST, F ;
KARPPINEN, K ;
HONKANEN, T ;
SAIJONMAA, O ;
ROSENLOF, K .
JOURNAL OF INTERNAL MEDICINE, 1989, 226 (04) :257-260
[9]   Mechanism of angiotensin converting enzyme inhibitor-related anemia in renal transplant recipients [J].
Gossmann, J ;
Thurmann, P ;
Bachmann, T ;
Weller, S ;
Kachel, HG ;
Schoeppe, W ;
Scheuermann, EH .
KIDNEY INTERNATIONAL, 1996, 50 (03) :973-978
[10]   Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway [J].
Gossmann, J ;
Burkhardt, R ;
Harder, S ;
Lenz, T ;
Sedlmeyer, A ;
Klinkhardt, U ;
Geiger, H ;
Scheuermann, EH .
KIDNEY INTERNATIONAL, 2001, 60 (01) :83-86